山东药玻
(600529)
| 流通市值：121.51亿 | | | 总市值：121.51亿 |
| 流通股本：6.64亿 | | | 总股本：6.64亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,219,063,985.04 | 4,474,018,978.75 | 3,352,070,071.23 | 2,250,208,818.82 |
| 营业收入 | 1,219,063,985.04 | 4,474,018,978.75 | 3,352,070,071.23 | 2,250,208,818.82 |
| 二、营业总成本 | 960,424,944.76 | 3,533,710,798.9 | 2,658,703,139.69 | 1,777,978,175.35 |
| 营业成本 | 822,101,029.11 | 2,983,735,053.33 | 2,227,231,212.57 | 1,499,268,271.78 |
| 税金及附加 | 15,842,271.92 | 51,340,606.36 | 37,676,460.66 | 25,032,717.94 |
| 销售费用 | 29,277,954.15 | 107,683,043.93 | 77,801,911.18 | 45,138,736.06 |
| 管理费用 | 51,384,369.95 | 232,409,811.05 | 194,166,835.56 | 128,031,063.82 |
| 研发费用 | 36,717,625.5 | 174,795,365.98 | 138,496,841.02 | 95,674,626.79 |
| 财务费用 | 5,101,694.13 | -16,253,081.75 | -16,670,121.3 | -15,167,241.04 |
| 其中:利息费用 | 706,059.83 | 514,193.21 | 18,210.41 | 11,153.73 |
| 其中:利息收入 | 3,868,752.38 | 12,852,652.03 | 11,705,229.47 | 7,888,019.25 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,138,682.51 | 9,136,242.46 | 7,987,785.22 | 6,447,381.91 |
| 加:投资收益 | 4,664,897.49 | 17,548,332.44 | 13,355,985.71 | 7,227,203.39 |
| 资产处置收益 | 37,608.29 | 1,452,467.75 | 808,971.47 | 417,482.36 |
| 资产减值损失(新) | -18,152,583.1 | -156,894,172.13 | -80,911,051.13 | -48,839,146.75 |
| 信用减值损失(新) | -10,627,038.12 | 3,946,360.61 | -74,651.04 | -4,459,841.93 |
| 其他收益 | 5,093,497.23 | 22,463,415.96 | 17,332,606.13 | 11,068,719.24 |
| 四、营业利润 | 241,794,104.58 | 837,960,826.94 | 651,866,577.9 | 444,092,441.69 |
| 加:营业外收入 | 260,330.19 | 2,349,125.79 | 1,777,673.44 | 1,103,350.42 |
| 减:营业外支出 | 2,824,946.99 | 9,481,883.94 | 5,252,955.54 | 3,648,149.62 |
| 五、利润总额 | 239,229,487.78 | 830,828,068.79 | 648,391,295.8 | 441,547,642.49 |
| 减:所得税费用 | 38,023,467.65 | 141,202,028.13 | 105,937,637.43 | 70,406,020.49 |
| 六、净利润 | 201,206,020.13 | 689,626,040.66 | 542,453,658.37 | 371,141,622 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 201,206,020.13 | 689,626,040.66 | 542,453,658.37 | 371,141,622 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 201,206,020.13 | 689,626,040.66 | 542,453,658.37 | 371,141,622 |
| 扣除非经常损益后的净利润 | 194,124,328.97 | 658,460,201.17 | 515,879,178.99 | 354,997,295.64 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.3 | 1.04 | 0.82 | 0.56 |
| (二)稀释每股收益 | 0.3 | 1.04 | 0.82 | 0.56 |
| 九、综合收益总额 | 201,206,020.13 | 689,626,040.66 | 542,453,658.37 | 371,141,622 |
| 归属于母公司股东的综合收益总额 | 201,206,020.13 | 689,626,040.66 | 542,453,658.37 | 371,141,622 |
| 公告日期 | 2026-04-25 | 2026-03-07 | 2025-10-28 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |